CMS issues new CCI edits for drug tests, nerve blocks

Why This Topic Matters

The update may affect claim submission and edit review workflows for practices that bill drug tests or selected nerve-related procedures. Understanding the scope of the change helps practices monitor code pairings, payer policy updates, and modifier-related edit status.

Article Sections

1. Quarterly CCI update affecting drug tests

   Overview of the new CMS edit update and the general category of services affected. The section frames the timing of the change and its impact on practices that perform drug testing.

2. Medicare contractor coverage activity

   Discussion of related Medicare administrative contractor work on a uniform local coverage determination for urine drug testing. This section summarizes the status of contractor proposals and comment periods.

3. Nerve block and pain management edit update

   Summary of a separate quarterly edit change involving diagnostic ultrasound services and selected pain management procedures. The section identifies the broader procedure groups involved.

4. Modifier use and resource

   Closing note on modifier-related edit handling and a CMS resource for quarterly PTP changes. This section points readers to the source update materials.